The Big Short: Australian Growth Stocks
In a recent update to investors, founder and CEO of Platinum Asset Management, Mr Kerr Nielson, cited that global conditions had been challenging...
390 Views
Opportunity Knocks as Mayne Pharma Makes A Transformational Acquisition
Mayne Pharma has agreed to buy a portfolio of U.S. generic products from Teva and Allergan for USD 652 million (AUD 881 million) in cash, primarily...
274 Views
Equity Best Ideas
The Best Ideas list is a compilation of stock ideas sourced from Morningstar’s global equity research team. Recent Asian additions: Allergan...
333 Views
Mayne Pharma Focuses on Building Brand and Maintaining Momentum for Doryx
Notwithstanding Mayne's significant investment already made and planned in United States manufacturing capacity, we have a positive outlook on the...
393 Views